Back to search

Identification of tamoxifen–DNA adducts in the endometrium of women treated with tamoxifen

Data up to Jan 2025

Published2000
Citations92
References29

Total Citations Per Year

Abstract

References (29)

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1998 • 5,487 citations

Tamoxifen for early breast cancer: an overview of the randomised trials

1998 • 4,082 citations

Tamoxifen in the Treatment of Breast Cancer

1998 • 1,295 citations

Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *

1994 • 1,259 citations

Tamoxifen Therapy for Breast Cancer and Endometrial Cancer Risk

1999 • 348 citations

The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat

1993 • 235 citations

Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts

1999 • 133 citations

A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes

1994 • 110 citations

A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism

1994 • 104 citations

32P-Postlabelled DNA adducts in liver obtained from women treated with tamoxifen

1995 • 100 citations

The tamoxifen dilemma

1999 • 96 citations

Detection of DNA adducts in HL-60 cells treated with hydroquinone and p-benzoquinone by 32P-postlabeling

1991 • 93 citations

Sulfation of alpha-hydroxytamoxifen catalyzed by human hydroxysteroid sulfotransferase results in tamoxifen-DNA adducts

1998 • 80 citations

Tamoxifen−DNA Adducts Detected in the Endometrium of Women Treated with Tamoxifen

1999 • 80 citations

Identification of Tamoxifen−DNA Adducts Formed by α-Sulfate Tamoxifen and α-Acetoxytamoxifen

1997 • 79 citations

Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates α-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen

1994 • 77 citations

Identification of tamoxifen-DNA adducts formed by 4-hydroxytamoxifen quinone methide

1997 • 66 citations

The metabolic activation of tamoxifen and alpha-hydroxytamoxifen to DNA- binding species in rat hepatocytes proceeds via sulphation

1998 • 61 citations

Does tamoxifen cause cancer in humans?

1998 • 60 citations

Lack of evidence from HPLC 32P-post-labelling for tamoxifenDNA adducts in the human endometrium

1999 • 58 citations

The deuterium isotope effect for the α-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifen

1995 • 53 citations

Comparison of the DNA adducts formed by tamoxifen and 4-hydroxytamoxifen in vivo

1999 • 50 citations

Aspects of metabolism of tamoxifen by rat liver microsomes

1986 • 43 citations

The mercenary business: ‘executive outcomes’

1997 • 41 citations

Evaluation of tamoxifen and alpha-hydroxytamoxifen 32P-post-labelled DNA adducts by the development of a novel automated on-line solid-phase extraction HPLC method

1998 • 38 citations

Minor products of reaction of DNA with alpha-acetoxytamoxifen

1997 • 33 citations

Miscoding Potential of Tamoxifen-Derived DNA Adducts: α-(N2-Deoxyguanosinyl)tamoxifen

1997 • 31 citations

Lifetime and Reactivity of an Ultimate Tamoxifen Carcinogen: The Tamoxifen Carbocation

1998 • 24 citations

Tamoxifen−DNA Adducts Formed by α-Acetoxytamoxifen N-Oxide

1999 • 17 citations

Cited By (0)

Loading...
Identification of tamoxifen–DNA adducts in the endometrium of women treated with tamoxifen (2000) – Carcinogenesis | Metascience Observatory Explorer